Brain Cancer Research - Symptoms, Benign and Malignant Tumors, Gliomas, Treatment

Brain Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Brain Cancer, including details on symptoms, benign and malignant tumors, gliomas, treatment.


Brain Cancer Research Today

Home

View Latest Issue

Information About Brain Cancer

Books on Brain Cancer

Advertising in Research Today

View Other Research Today Publications



Volume 7 (2010), Issue 12 (December)

  1. A cortical dysembryoplastic neuroepithelial tumor initially occurring in the periventricular white matter.
    J Neurosurg Pediatr, 6(6): 600-3. [Abstract] [Full-text]
  2. Treatment of third ventricular choroid plexus papilloma in an infant with embolization alone.
    J Neurosurg Pediatr, 6(6): 579-82. [Abstract] [Full-text]
  3. Pathological findings of fusiform dilation of the internal carotid artery following radical dissection of a craniopharyngioma.
    J Neurosurg Pediatr, 6(6): 567-71. [Abstract] [Full-text]
  4. Interaction between lung cancer cells and astrocytes via specific inflammatory cytokines in the microenvironment of brain metastasis.
    Clin Exp Metastasis, 28(1): 13-25. [Abstract] [Full-text]
  5. Interaction between lung cancer cells and astrocytes via specific inflammatory cytokines in the microenvironment of brain metastasis.
    Clin Exp Metastasis, 28(1): 13-25. [Abstract] [Full-text]
  6. TP53 mutation is frequently associated with CTNNB1 mutation or MYCN amplification and is compatible with long-term survival in medulloblastoma.
    J Clin Oncol, 28(35): 5188-96. [Abstract] [Full-text]
  7. Pituitary apoplexy: re-evaluation of risk factors for bleeding into pituitary adenomas and impact on outcome.
    Eur J Endocrinol, 164(1): 37-43. [Abstract] [Full-text]
  8. Proton radiotherapy for pediatric central nervous system germ cell tumors: early clinical outcomes.
    Int J Radiat Oncol Biol Phys, 79(1): 121-9. [Abstract] [Full-text]
  9. Pattern of failure after limited margin radiotherapy and temozolomide for glioblastoma.
    Int J Radiat Oncol Biol Phys, 79(1): 130-6. [Abstract] [Full-text]
  10. Pituitary apoplexy: re-evaluation of risk factors for bleeding into pituitary adenomas and impact on outcome.
    Eur J Endocrinol, 164(1): 37-43. [Abstract] [Full-text]
  11. Proton radiotherapy for pediatric central nervous system germ cell tumors: early clinical outcomes.
    Int J Radiat Oncol Biol Phys, 79(1): 121-9. [Abstract] [Full-text]
  12. Pattern of failure after limited margin radiotherapy and temozolomide for glioblastoma.
    Int J Radiat Oncol Biol Phys, 79(1): 130-6. [Abstract] [Full-text]
  13. Non-stem cell origin for oligodendroglioma.
    Cancer Cell, 18(6): 669-82. [Abstract] [Full-text]
  14. TGF-β Receptor Inhibitors Target the CD44(high)/Id1(high) Glioma-Initiating Cell Population in Human Glioblastoma.
    Cancer Cell, 18(6): 655-68. [Abstract] [Full-text]
  15. Survey of MicroRNA expression in pediatric brain tumors.
    Pediatr Blood Cancer, 56(2): 211-6. [Abstract] [Full-text]
  16. Posterior fossa syndrome after posterior fossa surgery in children with brain tumors.
    Pediatr Blood Cancer, 56(2): 206-10. [Abstract] [Full-text]
  17. Survey of MicroRNA expression in pediatric brain tumors.
    Pediatr Blood Cancer, 56(2): 211-6. [Abstract] [Full-text]
  18. Posterior fossa syndrome after posterior fossa surgery in children with brain tumors.
    Pediatr Blood Cancer, 56(2): 206-10. [Abstract] [Full-text]
  19. Survey of MicroRNA expression in pediatric brain tumors.
    Pediatr Blood Cancer, 56(2): 211-6. [Abstract] [Full-text]
  20. Posterior fossa syndrome after posterior fossa surgery in children with brain tumors.
    Pediatr Blood Cancer, 56(2): 206-10. [Abstract] [Full-text]
  21. Conditional deletion of the focal adhesion kinase FAK alters remodeling of the blood-brain barrier in glioma.
    Cancer Res, 70(24): 10131-40. [Abstract] [Full-text]
  22. Coexpression network analysis identifies transcriptional modules related to proastrocytic differentiation and sprouty signaling in glioma.
    Cancer Res, 70(24): 10060-70. [Abstract] [Full-text]
  23. Isolated extracranial recurrence of anaplastic ependymoma.
    Pediatr Blood Cancer, 56(2): 317-8. [Abstract] [Full-text]
  24. Isolated extracranial recurrence of anaplastic ependymoma.
    Pediatr Blood Cancer, 56(2): 317-8. [Abstract] [Full-text]
  25. Isolated extracranial recurrence of anaplastic ependymoma.
    Pediatr Blood Cancer, 56(2): 317-8. [Abstract] [Full-text]
  26. Clinical experience with Hedgehog pathway inhibitors.
    J Clin Oncol, 28(36): 5321-6. [Abstract] [Full-text]
  27. Inhibition of neurotrophin receptor p75 intramembran proteolysis by gamma-secretase inhibitor reduces medulloblastoma spinal metastasis.
    Biochem Biophys Res Commun, 403(3): 264-9. [Abstract] [Full-text]
  28. Statins use and risk for brain metastasis from lung cancer.
    Cancer Invest, 29(1): 68-72. [Abstract] [Full-text]
  29. Statins use and risk for brain metastasis from lung cancer.
    Cancer Invest, 29(1): 68-72. [Abstract] [Full-text]
  30. Diagnostic value of peritumoral minimum apparent diffusion coefficient for differentiation of glioblastoma multiforme from solitary metastatic lesions.
    AJR Am J Roentgenol, 196(1): 71-6. [Abstract] [Full-text]
  31. Reproductive factors and exogenous hormone use and risk of adult glioma in women in the NIH-AARP Diet and Health Study.
    Int J Cancer, 128(4): 944-50. [Abstract] [Full-text]
  32. Combined action of the dinuclear platinum compound BBR3610 with the PI3-K inhibitor PX-866 in glioblastoma.
    Int J Cancer, 128(4): 787-96. [Abstract] [Full-text]
  33. Reproductive factors and exogenous hormone use and risk of adult glioma in women in the NIH-AARP Diet and Health Study.
    Int J Cancer, 128(4): 944-50. [Abstract] [Full-text]
  34. Combined action of the dinuclear platinum compound BBR3610 with the PI3-K inhibitor PX-866 in glioblastoma.
    Int J Cancer, 128(4): 787-96. [Abstract] [Full-text]
  35. Reproductive factors and exogenous hormone use and risk of adult glioma in women in the NIH-AARP Diet and Health Study.
    Int J Cancer, 128(4): 944-50. [Abstract] [Full-text]
  36. Combined action of the dinuclear platinum compound BBR3610 with the PI3-K inhibitor PX-866 in glioblastoma.
    Int J Cancer, 128(4): 787-96. [Abstract] [Full-text]
  37. NFκB inhibitors induce cell death in glioblastomas.
    Biochem Pharmacol, 81(3): 412-24. [Abstract] [Full-text]
  38. NFκB inhibitors induce cell death in glioblastomas.
    Biochem Pharmacol, 81(3): 412-24. [Abstract] [Full-text]
  39. NFκB inhibitors induce cell death in glioblastomas.
    Biochem Pharmacol, 81(3): 412-24. [Abstract] [Full-text]
  40. Inhibitory action of methadone and its metabolites on erg-mediated K+ current in GH₃ pituitary tumor cells.
    Toxicology, 280(1): 1-9. [Abstract] [Full-text]
  41. Hemangioblastomas might derive from neoplastic transformation of neural stem cells/progenitors in the specific niche.
    Carcinogenesis, 32(1): 102-9. [Abstract] [Full-text]
  42. Magnetic resonance imaging findings in 40 dogs with histologically confirmed intracranial tumours.
    Vet J, 187(1): 85-91. [Abstract] [Full-text]
  43. Inhibitory action of methadone and its metabolites on erg-mediated K+ current in GH₃ pituitary tumor cells.
    Toxicology, 280(1): 1-9. [Abstract] [Full-text]
  44. Inhibitory action of methadone and its metabolites on erg-mediated K+ current in GH₃ pituitary tumor cells.
    Toxicology, 280(1): 1-9. [Abstract] [Full-text]
Place a permanent text-link or advertisement here.

© 2004-2012 Brain Cancer Research Today. All Rights Reserved.



Brain Cancer Research Today Archive:

Volume 1 (2004)
  Issue 1 (August)
  Issue 2 (September)
  Issue 3 (October)
  Issue 4 (November)
  Issue 5 (December)

Volume 2 (2005)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 3 (2006)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 4 (2007)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 5 (2008)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 6 (2009)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 7 (2010)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 8 (2011)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 9 (2012)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)



Brain Cancer Books

Coping With Cancer

Coping With Cancer